These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 14013303)
1. [Content of riboflavin in the organs of rats with transplanted tumors]. ANTEKAR'SG Arkh Patol; 1962; 24(10)():45-52. PubMed ID: 14013303 [No Abstract] [Full Text] [Related]
2. RIBOFLAVIN CONTENT IN ORGANS OF RATS WITH TRANSPLANTED TUMORS. APTEKAR SG Fed Proc Transl Suppl; 1963; 22():923-7. PubMed ID: 14060286 [No Abstract] [Full Text] [Related]
3. Liver transplant for hepatocellular carcinoma: experience in a Saudi population. Allam N; Khalaf H; Fagih M; Al-Sebayel M Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240 [TBL] [Abstract][Full Text] [Related]
4. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats. Mukherjee B; Das T; Ghosh S; Datta S Eur J Cancer Prev; 2007 Aug; 16(4):363-71. PubMed ID: 17554210 [TBL] [Abstract][Full Text] [Related]
5. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Hayashi PH; Trotter JF; Forman L; Kugelmas M; Steinberg T; Russ P; Wachs M; Bak T; Kam I; Everson GT Liver Transpl; 2004 Jan; 10(1):42-8. PubMed ID: 14755776 [TBL] [Abstract][Full Text] [Related]
6. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Silva M; Moya A; Berenguer M; Sanjuan F; López-Andujar R; Pareja E; Torres-Quevedo R; Aguilera V; Montalva E; De Juan M; Mattos A; Prieto M; Mir J Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681 [TBL] [Abstract][Full Text] [Related]
7. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice. Son G; Hirano T; Seki E; Iimuro Y; Nukiwa T; Matsumoto K; Nakamura T; Fujimoto J J Hepatol; 2006 Nov; 45(5):688-95. PubMed ID: 16839638 [TBL] [Abstract][Full Text] [Related]
8. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. Voss C; Zerban H; Bannasch P; Berger MR Toxicology; 2005 Jan; 206(3):359-71. PubMed ID: 15588926 [TBL] [Abstract][Full Text] [Related]
9. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309 [TBL] [Abstract][Full Text] [Related]
10. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Plessier A; Codes L; Consigny Y; Sommacale D; Dondero F; Cortes A; Degos F; Brillet PY; Vilgrain V; Paradis V; Belghiti J; Durand F Liver Transpl; 2004 Feb; 10(2 Suppl 1):S86-90. PubMed ID: 14762846 [TBL] [Abstract][Full Text] [Related]
11. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Pitman MB; Triratanachat S; Young RH; Oliva E Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular neoplasms after intrahepatic transplantation of ovarian fragments into ovariectomized rats. Dombrowski F; Flaschka C; Klotz L; von Netzer B; Schulz C; Lehnert H; Evert M Hepatology; 2006 Apr; 43(4):857-67. PubMed ID: 16557532 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for hepatocellular carcinoma < or = 3 cm in diameter. Hu RH; Lee PH; Chang YC; Yu SC; Ho MC; Wu YM Hepatogastroenterology; 2003; 50(54):2043-8. PubMed ID: 14696462 [TBL] [Abstract][Full Text] [Related]
14. Liver repopulation by transplanted hepatocytes and risk of hepatocellular carcinoma. Laconi S; Montisci S; Doratiotto S; Greco M; Pasciu D; Pillai S; Pani P; Laconi E Transplantation; 2006 Nov; 82(10):1319-23. PubMed ID: 17130781 [TBL] [Abstract][Full Text] [Related]
15. The initiation activity of norfloxacin does not result in the induction of hepatocellular tumors in rats. Itoh T; Moto M; Kuroiwa Y; Sakai H; Mitsumori K Toxicology; 2007 Mar; 231(2-3):234-42. PubMed ID: 17254688 [TBL] [Abstract][Full Text] [Related]
16. Is there a customised immunosuppressive regimen for patients transplanted with hepatocellular carcinoma? Majno P; Giostra E; Mentha G; J Hepatol; 2005 Oct; 43(4):577-84. PubMed ID: 16118027 [No Abstract] [Full Text] [Related]
17. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms. Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251 [TBL] [Abstract][Full Text] [Related]
18. Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by the transplanted cells in nude mice. Tsuboi S; Nouso K; Tomono Y; Nagamori S; Naito I; Watanabe T; Manabe K; Ohmori H; Nakatsukasa H; Miyazaki M; Higashi T; Shiratori Y; Namba M; Ninomiya Y Int J Oncol; 2004 Nov; 25(5):1267-71. PubMed ID: 15492814 [TBL] [Abstract][Full Text] [Related]
19. [Morphological changes in immunogenesis organs in transplantation of Guerin carcinoma to the spleen]. Bobro LI; Fil'chakov FV; Grinevich IuA; Shumilina ES Arkh Patol; 2004; 66(4):30-5. PubMed ID: 15449686 [TBL] [Abstract][Full Text] [Related]
20. Hepatoid carcinoma of the pancreas: a case report and literature review of a heterogeneous group of tumors. Hameed O; Xu H; Saddeghi S; Maluf H Am J Surg Pathol; 2007 Jan; 31(1):146-52. PubMed ID: 17197931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]